assess the clinical and laboratory effects of the local and sub gingival application of a 0.8% hyaluronic acid gel (GENGIGEL®) as an adjunct to scaling and root planning (SRP) in chronic moderate to severe periodontitis patients as indicated by expression of Human Beta Definsin-2 (HBD2) in gingival crevicular fluid (GCF).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical Attachment Level (CAL) change
Timeframe: baseline, six weeks, 12 weeks
Probing Depth change
Timeframe: baseline, six weeks, 12 weeks
Gingival Index change (Loe and Silness, 1963)
Timeframe: baseline, six weeks, 12 weeks
Plaque index change (Loe and Silness, 1964)
Timeframe: baseline, six weeks, 12 weeks
Papillary Bleeding Index change (Muhlemann, 1977)
Timeframe: baseline, six weeks, 12 weeks